Critical Assessment of Endoscopic Techniques for Gastroesophageal Reflux Disease

Journal of Clinical Gastroenterology

Volumn 49, Issue 9, 2015, Pages 720-724

  Lo, Wai Kit ^a,b,c   Mashimo, Hiroshi ^a,c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

advanced endoscopic techniques; endoscopic placation; gastroesophageal reflux disease; injectable bulking agents; radiofrequency

Indexed keywords

BULKING AGENT;

ANTI REFLUX IMPLANT; ARTICLE; CLINICAL ASSESSMENT; DIGESTIVE DEVICE; DISEASE MANAGEMENT; ELECTROSTIMULATION THERAPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMPLANTATION; PATIENT SAFETY; PRIORITY JOURNAL; PULSED RADIOFREQUENCY TREATMENT; STOMACH FUNDOPLICATION; SYMPTOM; ADVERSE EFFECTS; CATHETER ABLATION; GASTROESOPHAGEAL JUNCTION; METABOLISM; PROCEDURES;

CATHETER ABLATION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGOGASTRIC JUNCTION; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 84942118461     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000389     Document Type: Article

References (52)

1. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871-880.
2. Kaltenback T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease An evidence-based approach. Arch Int Med. 2006;166:965-971.
3. Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep. 2015;3:41-53.
4. Jo YJ. Proton pump inhibitors reduce the size and acidity of the gastric acid pocket. J Neurogastroenterol Motil. 2015; 21:133-134.
5. Alsalahi O, Dobrian AD. Proton pump inhibitors: the culprit for Barrett's esophagus Front Oncol. 2015;4:373.
6. Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010;12:448-457.
7. Janarthanan S, Ditah I, Adler DG, et al. Clostridium difficileassociated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001-1010.
8. Filion KB, Chateau D, Targownik LE, et al. Proton pump inhibitors and the risk of hospitalization for communityacquired pneumonia: replicated cohort studies with metaanalysis. Gut. 2014;63:552-558.
9. Lo W-K, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483-490.
10. Galmiche J-P, Hatlebakk J, Attwood S, et al. Laparoscsopic antireflux surgery vs esomeprazole treatment for chronic GERD, The LOTUS randomized clinical trial. JAMA. 2011;305:1969-1977.
11. Arts J, Bisschops R, Blondeau K, et al. A double-blind shamcontrolled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107:222-230.
12. Tam WCE, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003;52:479-485.
13. Utley DS, Kim M, Vierra MA, et al. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc. 2000;52:81-86.
14. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22:283-288.
15. Aziz AM, El-Khayat HR, Sadek A, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Curr Opin Gastroenterol. 2009;25:352-357.
16. Corley DA, Katz P, Wo JM, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003; 125:668-676.
17. Coron E, Sebille V, Cadiot G, et al. Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther. 2008;28:1147-1158.
18. Auyang ED, Carter P, Rauth T, et al. and the SAGES Guidelines Committee. SAGES clinical spotlight reivew: endoluminal treatments for gastroesophageal reflux disease (GERD). Surg Endosc. 2013;27:2658-2672.
19. Dughera L, Rotondano G, De Cento M, et al. Durability of Stretta radiofrequency treatment for GERD: results of an 8-year follow-up. Gastroenterol Res Pract. 2014;2014:531907.
20. Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323-2333.
21. Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease. Minerva Chir. 2014;69:217-223.
22. Jeansonne LO IV, White BC, Nguyen V, et al. Endoluminal full-thickness plication and radiofrequency treatments for GERD: an outcomes comparison. Arch Surg. 2009;144:19-24.
23. McClusky DA III, Khaitan L, Swafford VA, et al. Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery. Surg Endosc. 2007;21:1207-1211.
24. Chen YK, Raijman I, Ben-Menachem T, et al. Long-term outcomes of endoluminal gastroplication: a US multicenter trial. Gastrointest Endosc. 2005;61:659-667.
25. Schwartz MP, Wellink H, Gooszen HG, et al. Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut. 2007;56: 20-28.
26. Schwartz MP, Schreinemakers JR, Smout AJ. Four-year follow-up of endoscopic gastroplication for the treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2013;4:120-126.
27. Abou-Rebyeh H, Hoepffner N, Ro sch T, et al. Long-term failure of endoscopic suturing in the treatment of gastroesophageal reflux: a prospective follow-up study. Endoscopy. 2005;37:213-216.
28. Schiefke I, Zabel-Langhennig A, Neumann S, et al. Long term failure of endoscopic gastroplication (EndoCinch). Gut. 2005;54:752-758.
29. Rothstein R, Filipi C, Caca K, et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial. Gastroenterology. 2006;131: 704-712.
30. Pleskow D, Rothstein R, Kozarek R, et al. Endoscopic fullthickness plication for the treatment of GERD: five-year longterm multicenter results. Surg Endosc. 2008;22:326-332.
31. von Renteln D, Schiefke I, Fuchs KH, et al. Endoscopic fullthickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results. Surg Endosc. 2009;23:1866-1875.
32. Kaindlstorfer A, Koch OO, Antoniou SA, et al. A randomized trial on endoscopic full-thickness gastroplication versus laparoscopic antireflux surgery in GERD patients without hiatal hernias. Surg Laparosc Endosc Percutan Tech. 2013;23: 212-222.
33. Rinsma NF, Smeets FG, Bruls DW, et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc. 2014;28:941-949.
34. Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSEt) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220-229.
35. Ihde G, Besancon K, Deljkich E. Short term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg. 2011;202:740-747.
36. Trad KS, Barnes WE, Simoni G, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22:26-40.
37. Muls V, Eckardt AJ, Marchese M, et al. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov. 2013;20:321-330.
38. Wendling MR, Melvin WS, Perry KA. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature. Surg Endosc. 2013;27:3754-3761.
39. Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148: 324-333.
40. Wilson EB, Barnes WE, Mavrelis PG, et al. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech. 2014;24:36-46.
41. Witteman BP, Kessing BF, Snijders G, et al. Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication. Surg Endosc. 2013;27:2231-2236.
42. Frazzoni M, Conigliaro R, Manta R, et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67-75.
43. O'Connor KW, Lehman GA. Endoscopic placement of collagen at the lower esophageal sphincter to inhibit gastroesophageal reflux: a pilot study of 10 medically intractable patients. Gastrointest Endosc. 1988;34:106-112.
44. Fockens P, Cohen L, Edmundowicz SA, et al. Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease. Surg Endosc. 2010; 24:1387-1397.
45. Feretis C, Benakis P, Dimopoulos C, et al. Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc. 2001;53:423-426.
46. Fornari F, Freitag CP, Duarte ME, et al. Endoscopic augmentation of the esophagogastric junction with polymethylmethacrylate: durability, safety, and efficacy after 6 months in mini-pigs. Surg Endosc. 2009;23:2430-2437.
47. Kamler JP, Lemperle G, Lemperle S, et al. Endoscopic lower esophageal sphincter bulking for the treatment of GERD: safety evaluation of injectable polymethylmethacrylate microspheres in miniature swine. Gastrointest Endosc. 2010;72: 337-342.
48. Ganz RA, Fallon E, Wittchow T, et al. A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial. Gastrointest Endosc. 2009;69:318-323.
49. Katz PO, Gerson LB, Vela MF. Diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108: 308-328.
50. Franciosa M, Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality. Am J Gastroenterol. 2013;108:1654-1655.
51. ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015; 81:1305-1310.
52. Kahrilas PJ, Shaheen NJ, Vaezi MV. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392-1413.